nodes	percent_of_prediction	percent_of_DWPC	metapath
Treprostinil—PTGIR—brainstem—multiple sclerosis	0.00519	0.11	CbGeAlD
Treprostinil—PPARD—midbrain—multiple sclerosis	0.00431	0.091	CbGeAlD
Treprostinil—P2RY12—nervous system—multiple sclerosis	0.00426	0.0901	CbGeAlD
Treprostinil—P2RY12—central nervous system—multiple sclerosis	0.00411	0.0867	CbGeAlD
Treprostinil—PPARD—nervous system—multiple sclerosis	0.00354	0.0748	CbGeAlD
Treprostinil—PPARD—central nervous system—multiple sclerosis	0.00341	0.0721	CbGeAlD
Treprostinil—PPARD—cerebellum—multiple sclerosis	0.00333	0.0704	CbGeAlD
Treprostinil—P2RY12—brain—multiple sclerosis	0.00326	0.0689	CbGeAlD
Treprostinil—PTGIR—spinal cord—multiple sclerosis	0.00323	0.0682	CbGeAlD
Treprostinil—PTGIR—nervous system—multiple sclerosis	0.00272	0.0575	CbGeAlD
Treprostinil—PPARD—brain—multiple sclerosis	0.00271	0.0572	CbGeAlD
Treprostinil—PTGIR—central nervous system—multiple sclerosis	0.00262	0.0553	CbGeAlD
Treprostinil—PTGIR—cerebellum—multiple sclerosis	0.00256	0.0541	CbGeAlD
Treprostinil—PTGIR—brain—multiple sclerosis	0.00208	0.0439	CbGeAlD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	0.00108	0.00269	CbGpPWpGaD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.00106	0.00262	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	0.00105	0.00262	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—S1PR1—multiple sclerosis	0.00104	0.00258	CbGpPWpGaD
Treprostinil—P2RY12—G alpha (i) signalling events—CCL5—multiple sclerosis	0.00103	0.00256	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—SRM—multiple sclerosis	0.00101	0.00252	CbGpPWpGaD
Treprostinil—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.00101	0.0025	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—SELE—multiple sclerosis	0.001	0.00249	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—U2AF2—multiple sclerosis	0.000988	0.00246	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—HNRNPA1—multiple sclerosis	0.000988	0.00246	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.000972	0.00241	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—CCL3—multiple sclerosis	0.000963	0.00239	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	0.00096	0.00239	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—S1PR1—multiple sclerosis	0.000954	0.00237	CbGpPWpGaD
Treprostinil—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000951	0.00173	CcSEcCtD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.000951	0.00236	CbGpPWpGaD
Treprostinil—Loss of consciousness—Prednisolone—multiple sclerosis	0.000942	0.00171	CcSEcCtD
Treprostinil—P2RY12—Signaling by GPCR—S1PR1—multiple sclerosis	0.000941	0.00234	CbGpPWpGaD
Treprostinil—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000939	0.00171	CcSEcCtD
Treprostinil—P2RY12—GPCR ligand binding—PTGER4—multiple sclerosis	0.000927	0.0023	CbGpPWpGaD
Treprostinil—P2RY12—G alpha (i) signalling events—CCR5—multiple sclerosis	0.000927	0.0023	CbGpPWpGaD
Treprostinil—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000927	0.00169	CcSEcCtD
Treprostinil—PTGIR—Hemostasis—SELE—multiple sclerosis	0.000922	0.00229	CbGpPWpGaD
Treprostinil—Fatigue—Mitoxantrone—multiple sclerosis	0.00092	0.00167	CcSEcCtD
Treprostinil—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.000915	0.00166	CcSEcCtD
Treprostinil—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.000913	0.00166	CcSEcCtD
Treprostinil—Pain—Mitoxantrone—multiple sclerosis	0.000912	0.00166	CcSEcCtD
Treprostinil—Bradycardia—Prednisone—multiple sclerosis	0.000911	0.00166	CcSEcCtD
Treprostinil—Diarrhoea—Azathioprine—multiple sclerosis	0.000903	0.00164	CcSEcCtD
Treprostinil—Discomfort—Prednisolone—multiple sclerosis	0.000902	0.00164	CcSEcCtD
Treprostinil—Angioedema—Triamcinolone—multiple sclerosis	0.000901	0.00164	CcSEcCtD
Treprostinil—Haemoglobin—Prednisone—multiple sclerosis	0.0009	0.00163	CcSEcCtD
Treprostinil—Angioedema—Methylprednisolone—multiple sclerosis	0.000899	0.00163	CcSEcCtD
Treprostinil—Abdominal discomfort—Methotrexate—multiple sclerosis	0.000896	0.00163	CcSEcCtD
Treprostinil—P2RY12—GPCR ligand binding—CXCR3—multiple sclerosis	0.000896	0.00223	CbGpPWpGaD
Treprostinil—Haemorrhage—Prednisone—multiple sclerosis	0.000895	0.00163	CcSEcCtD
Treprostinil—Erythema—Betamethasone—multiple sclerosis	0.000895	0.00163	CcSEcCtD
Treprostinil—Erythema—Dexamethasone—multiple sclerosis	0.000895	0.00163	CcSEcCtD
Treprostinil—PPARD—Generic Transcription Pathway—PGR—multiple sclerosis	0.000894	0.00222	CbGpPWpGaD
Treprostinil—Malaise—Triamcinolone—multiple sclerosis	0.000889	0.00162	CcSEcCtD
Treprostinil—Malaise—Methylprednisolone—multiple sclerosis	0.000887	0.00161	CcSEcCtD
Treprostinil—PTGIR—GPCR ligand binding—CCL3—multiple sclerosis	0.000887	0.0022	CbGpPWpGaD
Treprostinil—Syncope—Triamcinolone—multiple sclerosis	0.000884	0.00161	CcSEcCtD
Treprostinil—Syncope—Methylprednisolone—multiple sclerosis	0.000882	0.0016	CcSEcCtD
Treprostinil—P2RY12—GPCR downstream signaling—RGS1—multiple sclerosis	0.000881	0.00219	CbGpPWpGaD
Treprostinil—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000879	0.0016	CcSEcCtD
Treprostinil—Oedema—Prednisolone—multiple sclerosis	0.000875	0.00159	CcSEcCtD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.000875	0.00217	CbGpPWpGaD
Treprostinil—Dizziness—Azathioprine—multiple sclerosis	0.000873	0.00159	CcSEcCtD
Treprostinil—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000872	0.00159	CcSEcCtD
Treprostinil—P2RY12—GPCR ligand binding—CCR2—multiple sclerosis	0.000871	0.00217	CbGpPWpGaD
Treprostinil—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000867	0.00158	CcSEcCtD
Treprostinil—PTGIR—Signaling by GPCR—S1PR1—multiple sclerosis	0.000866	0.00215	CbGpPWpGaD
Treprostinil—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000865	0.00157	CcSEcCtD
Treprostinil—Shock—Prednisolone—multiple sclerosis	0.000861	0.00156	CcSEcCtD
Treprostinil—P2RY12—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.00086	0.00214	CbGpPWpGaD
Treprostinil—Cough—Triamcinolone—multiple sclerosis	0.00086	0.00156	CcSEcCtD
Treprostinil—Tachycardia—Prednisolone—multiple sclerosis	0.000854	0.00155	CcSEcCtD
Treprostinil—PTGIR—GPCR ligand binding—PTGER4—multiple sclerosis	0.000853	0.00212	CbGpPWpGaD
Treprostinil—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000843	0.00153	CcSEcCtD
Treprostinil—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000843	0.00153	CcSEcCtD
Treprostinil—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	0.00084	0.00209	CbGpPWpGaD
Treprostinil—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	0.00084	0.00209	CbGpPWpGaD
Treprostinil—Myalgia—Triamcinolone—multiple sclerosis	0.000839	0.00153	CcSEcCtD
Treprostinil—Vomiting—Azathioprine—multiple sclerosis	0.000839	0.00152	CcSEcCtD
Treprostinil—Pneumonia—Methotrexate—multiple sclerosis	0.000838	0.00152	CcSEcCtD
Treprostinil—Myalgia—Methylprednisolone—multiple sclerosis	0.000838	0.00152	CcSEcCtD
Treprostinil—Arthralgia—Methylprednisolone—multiple sclerosis	0.000838	0.00152	CcSEcCtD
Treprostinil—P2RY12—GPCR downstream signaling—GPR65—multiple sclerosis	0.000835	0.00208	CbGpPWpGaD
Treprostinil—Anxiety—Methylprednisolone—multiple sclerosis	0.000835	0.00152	CcSEcCtD
Treprostinil—Rash—Azathioprine—multiple sclerosis	0.000832	0.00151	CcSEcCtD
Treprostinil—Dermatitis—Azathioprine—multiple sclerosis	0.000831	0.00151	CcSEcCtD
Treprostinil—Depression—Methotrexate—multiple sclerosis	0.000831	0.00151	CcSEcCtD
Treprostinil—Flushing—Prednisone—multiple sclerosis	0.000831	0.00151	CcSEcCtD
Treprostinil—Ill-defined disorder—Betamethasone—multiple sclerosis	0.00083	0.00151	CcSEcCtD
Treprostinil—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.00083	0.00151	CcSEcCtD
Treprostinil—Discomfort—Triamcinolone—multiple sclerosis	0.000829	0.00151	CcSEcCtD
Treprostinil—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000829	0.00206	CbGpPWpGaD
Treprostinil—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000829	0.00206	CbGpPWpGaD
Treprostinil—Discomfort—Methylprednisolone—multiple sclerosis	0.000828	0.0015	CcSEcCtD
Treprostinil—Headache—Azathioprine—multiple sclerosis	0.000827	0.0015	CcSEcCtD
Treprostinil—PPARD—Wnt Signaling Pathway and Pluripotency—MYC—multiple sclerosis	0.000825	0.00205	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—CXCR3—multiple sclerosis	0.000824	0.00205	CbGpPWpGaD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.000818	0.00203	CbGpPWpGaD
Treprostinil—Angioedema—Betamethasone—multiple sclerosis	0.000818	0.00149	CcSEcCtD
Treprostinil—Angioedema—Dexamethasone—multiple sclerosis	0.000818	0.00149	CcSEcCtD
Treprostinil—PTGIR—GPCR downstream signaling—RGS1—multiple sclerosis	0.000811	0.00202	CbGpPWpGaD
Treprostinil—Malaise—Dexamethasone—multiple sclerosis	0.000807	0.00147	CcSEcCtD
Treprostinil—Malaise—Betamethasone—multiple sclerosis	0.000807	0.00147	CcSEcCtD
Treprostinil—Oedema—Triamcinolone—multiple sclerosis	0.000805	0.00146	CcSEcCtD
Treprostinil—P2RY12—GPCR ligand binding—CNR1—multiple sclerosis	0.000804	0.002	CbGpPWpGaD
Treprostinil—Syncope—Betamethasone—multiple sclerosis	0.000802	0.00146	CcSEcCtD
Treprostinil—Syncope—Dexamethasone—multiple sclerosis	0.000802	0.00146	CcSEcCtD
Treprostinil—PTGIR—GPCR ligand binding—CCR2—multiple sclerosis	0.000802	0.00199	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—RGS1—multiple sclerosis	0.0008	0.00199	CbGpPWpGaD
Treprostinil—Infection—Triamcinolone—multiple sclerosis	0.000799	0.00145	CcSEcCtD
Treprostinil—Infection—Methylprednisolone—multiple sclerosis	0.000798	0.00145	CcSEcCtD
Treprostinil—Haematuria—Methotrexate—multiple sclerosis	0.000794	0.00144	CcSEcCtD
Treprostinil—PTGIR—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.000792	0.00197	CbGpPWpGaD
Treprostinil—Shock—Triamcinolone—multiple sclerosis	0.000792	0.00144	CcSEcCtD
Treprostinil—Insomnia—Prednisolone—multiple sclerosis	0.000791	0.00144	CcSEcCtD
Treprostinil—Shock—Methylprednisolone—multiple sclerosis	0.00079	0.00144	CcSEcCtD
Treprostinil—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000786	0.00143	CcSEcCtD
Treprostinil—Loss of consciousness—Betamethasone—multiple sclerosis	0.000786	0.00143	CcSEcCtD
Treprostinil—Epistaxis—Methotrexate—multiple sclerosis	0.000786	0.00143	CcSEcCtD
Treprostinil—Paraesthesia—Prednisolone—multiple sclerosis	0.000786	0.00143	CcSEcCtD
Treprostinil—Tachycardia—Triamcinolone—multiple sclerosis	0.000785	0.00143	CcSEcCtD
Treprostinil—Nausea—Azathioprine—multiple sclerosis	0.000784	0.00142	CcSEcCtD
Treprostinil—Tachycardia—Methylprednisolone—multiple sclerosis	0.000784	0.00142	CcSEcCtD
Treprostinil—PPARD—Gene Expression—ZFP36L1—multiple sclerosis	0.000781	0.00194	CbGpPWpGaD
Treprostinil—Erythema—Prednisone—multiple sclerosis	0.000779	0.00142	CcSEcCtD
Treprostinil—PTGIR—GPCR downstream signaling—GPR65—multiple sclerosis	0.000769	0.00191	CbGpPWpGaD
Treprostinil—Asthenia—Mitoxantrone—multiple sclerosis	0.000765	0.00139	CcSEcCtD
Treprostinil—P2RY12—GPCR downstream signaling—CCR1—multiple sclerosis	0.000764	0.0019	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000764	0.0019	CbGpPWpGaD
Treprostinil—Myalgia—Betamethasone—multiple sclerosis	0.000762	0.00138	CcSEcCtD
Treprostinil—Myalgia—Dexamethasone—multiple sclerosis	0.000762	0.00138	CcSEcCtD
Treprostinil—Anxiety—Betamethasone—multiple sclerosis	0.000759	0.00138	CcSEcCtD
Treprostinil—Anxiety—Dexamethasone—multiple sclerosis	0.000759	0.00138	CcSEcCtD
Treprostinil—P2RY12—Signaling by GPCR—GPR65—multiple sclerosis	0.000759	0.00189	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.000753	0.00187	CbGpPWpGaD
Treprostinil—Discomfort—Dexamethasone—multiple sclerosis	0.000753	0.00137	CcSEcCtD
Treprostinil—Discomfort—Betamethasone—multiple sclerosis	0.000753	0.00137	CcSEcCtD
Treprostinil—Haemoglobin—Methotrexate—multiple sclerosis	0.000752	0.00137	CcSEcCtD
Treprostinil—Hypotension—Methylprednisolone—multiple sclerosis	0.00075	0.00136	CcSEcCtD
Treprostinil—Pain—Prednisolone—multiple sclerosis	0.000748	0.00136	CcSEcCtD
Treprostinil—Haemorrhage—Methotrexate—multiple sclerosis	0.000748	0.00136	CcSEcCtD
Treprostinil—Pharyngitis—Methotrexate—multiple sclerosis	0.000742	0.00135	CcSEcCtD
Treprostinil—PTGIR—GPCR ligand binding—CNR1—multiple sclerosis	0.00074	0.00184	CbGpPWpGaD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000737	0.00183	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—RGS1—multiple sclerosis	0.000736	0.00183	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—LINGO1—multiple sclerosis	0.000734	0.00182	CbGpPWpGaD
Treprostinil—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000733	0.00133	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000732	0.00133	CcSEcCtD
Treprostinil—PPARD—Adipogenesis—STAT3—multiple sclerosis	0.000732	0.00182	CbGpPWpGaD
Treprostinil—Oedema—Betamethasone—multiple sclerosis	0.00073	0.00133	CcSEcCtD
Treprostinil—Oedema—Dexamethasone—multiple sclerosis	0.00073	0.00133	CcSEcCtD
Treprostinil—Diarrhoea—Mitoxantrone—multiple sclerosis	0.00073	0.00133	CcSEcCtD
Treprostinil—Insomnia—Triamcinolone—multiple sclerosis	0.000728	0.00132	CcSEcCtD
Treprostinil—Insomnia—Methylprednisolone—multiple sclerosis	0.000726	0.00132	CcSEcCtD
Treprostinil—Infection—Dexamethasone—multiple sclerosis	0.000725	0.00132	CcSEcCtD
Treprostinil—Infection—Betamethasone—multiple sclerosis	0.000725	0.00132	CcSEcCtD
Treprostinil—P2RY12—G alpha (i) signalling events—POMC—multiple sclerosis	0.000725	0.0018	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—ITGA4—multiple sclerosis	0.000724	0.0018	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—CXCL10—multiple sclerosis	0.000724	0.0018	CbGpPWpGaD
Treprostinil—Ill-defined disorder—Prednisone—multiple sclerosis	0.000723	0.00131	CcSEcCtD
Treprostinil—Paraesthesia—Triamcinolone—multiple sclerosis	0.000723	0.00131	CcSEcCtD
Treprostinil—Feeling abnormal—Prednisolone—multiple sclerosis	0.000721	0.00131	CcSEcCtD
Treprostinil—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000721	0.00131	CcSEcCtD
Treprostinil—Anaemia—Prednisone—multiple sclerosis	0.00072	0.00131	CcSEcCtD
Treprostinil—P2RY12—Hemostasis—IFNB1—multiple sclerosis	0.000719	0.00179	CbGpPWpGaD
Treprostinil—Shock—Dexamethasone—multiple sclerosis	0.000718	0.00131	CcSEcCtD
Treprostinil—Shock—Betamethasone—multiple sclerosis	0.000718	0.00131	CcSEcCtD
Treprostinil—Dyspnoea—Triamcinolone—multiple sclerosis	0.000717	0.0013	CcSEcCtD
Treprostinil—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000715	0.0013	CcSEcCtD
Treprostinil—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000715	0.0013	CcSEcCtD
Treprostinil—PPARD—Metabolism—CYP24A1—multiple sclerosis	0.000715	0.00178	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—CYP27B1—multiple sclerosis	0.000715	0.00178	CbGpPWpGaD
Treprostinil—Tachycardia—Dexamethasone—multiple sclerosis	0.000713	0.0013	CcSEcCtD
Treprostinil—Tachycardia—Betamethasone—multiple sclerosis	0.000713	0.0013	CcSEcCtD
Treprostinil—Angioedema—Prednisone—multiple sclerosis	0.000712	0.00129	CcSEcCtD
Treprostinil—Dyspepsia—Triamcinolone—multiple sclerosis	0.000708	0.00129	CcSEcCtD
Treprostinil—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000707	0.00128	CcSEcCtD
Treprostinil—PTGIR—GPCR downstream signaling—CCR1—multiple sclerosis	0.000703	0.00175	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000703	0.00175	CbGpPWpGaD
Treprostinil—Malaise—Prednisone—multiple sclerosis	0.000703	0.00128	CcSEcCtD
Treprostinil—Syncope—Prednisone—multiple sclerosis	0.000699	0.00127	CcSEcCtD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000698	0.00174	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—GPR65—multiple sclerosis	0.000698	0.00173	CbGpPWpGaD
Treprostinil—Anorexia—Betamethasone—multiple sclerosis	0.000696	0.00126	CcSEcCtD
Treprostinil—Anorexia—Dexamethasone—multiple sclerosis	0.000696	0.00126	CcSEcCtD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—ALB—multiple sclerosis	0.000694	0.00172	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—CXCL13—multiple sclerosis	0.000694	0.00172	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—CCR1—multiple sclerosis	0.000694	0.00172	CbGpPWpGaD
Treprostinil—Fatigue—Triamcinolone—multiple sclerosis	0.000694	0.00126	CcSEcCtD
Treprostinil—Fatigue—Methylprednisolone—multiple sclerosis	0.000692	0.00126	CcSEcCtD
Treprostinil—Pain—Triamcinolone—multiple sclerosis	0.000688	0.00125	CcSEcCtD
Treprostinil—Loss of consciousness—Prednisone—multiple sclerosis	0.000685	0.00124	CcSEcCtD
Treprostinil—Hypotension—Dexamethasone—multiple sclerosis	0.000682	0.00124	CcSEcCtD
Treprostinil—Hypotension—Betamethasone—multiple sclerosis	0.000682	0.00124	CcSEcCtD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000678	0.00169	CbGpPWpGaD
Treprostinil—Vomiting—Mitoxantrone—multiple sclerosis	0.000678	0.00123	CcSEcCtD
Treprostinil—PPARD—Adipogenesis—TGFB1—multiple sclerosis	0.000678	0.00169	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—LINGO1—multiple sclerosis	0.000675	0.00168	CbGpPWpGaD
Treprostinil—Rash—Mitoxantrone—multiple sclerosis	0.000673	0.00122	CcSEcCtD
Treprostinil—Dermatitis—Mitoxantrone—multiple sclerosis	0.000672	0.00122	CcSEcCtD
Treprostinil—Headache—Mitoxantrone—multiple sclerosis	0.000668	0.00121	CcSEcCtD
Treprostinil—PTGIR—Hemostasis—ITGA4—multiple sclerosis	0.000667	0.00166	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—CXCL10—multiple sclerosis	0.000666	0.00166	CbGpPWpGaD
Treprostinil—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000665	0.00121	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000665	0.00121	CcSEcCtD
Treprostinil—Myalgia—Prednisone—multiple sclerosis	0.000663	0.00121	CcSEcCtD
Treprostinil—Arthralgia—Prednisone—multiple sclerosis	0.000663	0.00121	CcSEcCtD
Treprostinil—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000663	0.00121	CcSEcCtD
Treprostinil—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000662	0.0012	CcSEcCtD
Treprostinil—PTGIR—Hemostasis—IFNB1—multiple sclerosis	0.000662	0.00164	CbGpPWpGaD
Treprostinil—Anxiety—Prednisone—multiple sclerosis	0.000661	0.0012	CcSEcCtD
Treprostinil—Insomnia—Betamethasone—multiple sclerosis	0.00066	0.0012	CcSEcCtD
Treprostinil—Insomnia—Dexamethasone—multiple sclerosis	0.00066	0.0012	CcSEcCtD
Treprostinil—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000657	0.00119	CcSEcCtD
Treprostinil—Paraesthesia—Dexamethasone—multiple sclerosis	0.000656	0.00119	CcSEcCtD
Treprostinil—Paraesthesia—Betamethasone—multiple sclerosis	0.000656	0.00119	CcSEcCtD
Treprostinil—Discomfort—Prednisone—multiple sclerosis	0.000655	0.00119	CcSEcCtD
Treprostinil—PPARD—Metabolism—GPC5—multiple sclerosis	0.000654	0.00162	CbGpPWpGaD
Treprostinil—Erythema—Methotrexate—multiple sclerosis	0.000651	0.00118	CcSEcCtD
Treprostinil—PPARD—Ectoderm Differentiation—MYC—multiple sclerosis	0.000648	0.00161	CbGpPWpGaD
Treprostinil—Dyspepsia—Dexamethasone—multiple sclerosis	0.000643	0.00117	CcSEcCtD
Treprostinil—Dyspepsia—Betamethasone—multiple sclerosis	0.000643	0.00117	CcSEcCtD
Treprostinil—PTGIR—Signaling by GPCR—CXCL13—multiple sclerosis	0.000639	0.00159	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CCR1—multiple sclerosis	0.000639	0.00159	CbGpPWpGaD
Treprostinil—Body temperature increased—Triamcinolone—multiple sclerosis	0.000636	0.00116	CcSEcCtD
Treprostinil—P2RY12—Signaling Pathways—TAGAP—multiple sclerosis	0.000636	0.00158	CbGpPWpGaD
Treprostinil—Oedema—Prednisone—multiple sclerosis	0.000636	0.00116	CcSEcCtD
Treprostinil—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000635	0.00115	CcSEcCtD
Treprostinil—Decreased appetite—Betamethasone—multiple sclerosis	0.000635	0.00115	CcSEcCtD
Treprostinil—Decreased appetite—Dexamethasone—multiple sclerosis	0.000635	0.00115	CcSEcCtD
Treprostinil—Nausea—Mitoxantrone—multiple sclerosis	0.000634	0.00115	CcSEcCtD
Treprostinil—PPARD—Adipogenesis—TNF—multiple sclerosis	0.000633	0.00157	CbGpPWpGaD
Treprostinil—Infection—Prednisone—multiple sclerosis	0.000632	0.00115	CcSEcCtD
Treprostinil—Back pain—Methotrexate—multiple sclerosis	0.00063	0.00114	CcSEcCtD
Treprostinil—Fatigue—Dexamethasone—multiple sclerosis	0.00063	0.00114	CcSEcCtD
Treprostinil—Fatigue—Betamethasone—multiple sclerosis	0.00063	0.00114	CcSEcCtD
Treprostinil—Shock—Prednisone—multiple sclerosis	0.000626	0.00114	CcSEcCtD
Treprostinil—PPARD—Generic Transcription Pathway—VDR—multiple sclerosis	0.000624	0.00155	CbGpPWpGaD
Treprostinil—Pain—Betamethasone—multiple sclerosis	0.000624	0.00113	CcSEcCtD
Treprostinil—Pain—Dexamethasone—multiple sclerosis	0.000624	0.00113	CcSEcCtD
Treprostinil—P2RY12—GPCR ligand binding—CCL5—multiple sclerosis	0.000623	0.00155	CbGpPWpGaD
Treprostinil—Tachycardia—Prednisone—multiple sclerosis	0.000621	0.00113	CcSEcCtD
Treprostinil—PPARD—NRF2 pathway—TGFB1—multiple sclerosis	0.000618	0.00154	CbGpPWpGaD
Treprostinil—Anorexia—Prednisone—multiple sclerosis	0.000606	0.0011	CcSEcCtD
Treprostinil—PPARD—Gene Expression—PABPC1—multiple sclerosis	0.000606	0.00151	CbGpPWpGaD
Treprostinil—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000604	0.0011	CcSEcCtD
Treprostinil—Anaemia—Methotrexate—multiple sclerosis	0.000602	0.00109	CcSEcCtD
Treprostinil—Feeling abnormal—Betamethasone—multiple sclerosis	0.000602	0.00109	CcSEcCtD
Treprostinil—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000602	0.00109	CcSEcCtD
Treprostinil—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000597	0.00109	CcSEcCtD
Treprostinil—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000597	0.00109	CcSEcCtD
Treprostinil—Malaise—Methotrexate—multiple sclerosis	0.000587	0.00107	CcSEcCtD
Treprostinil—PTGIR—Signaling Pathways—TAGAP—multiple sclerosis	0.000585	0.00145	CbGpPWpGaD
Treprostinil—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000579	0.00105	CcSEcCtD
Treprostinil—Dizziness—Prednisolone—multiple sclerosis	0.000579	0.00105	CcSEcCtD
Treprostinil—Asthenia—Triamcinolone—multiple sclerosis	0.000577	0.00105	CcSEcCtD
Treprostinil—Body temperature increased—Betamethasone—multiple sclerosis	0.000577	0.00105	CcSEcCtD
Treprostinil—Body temperature increased—Dexamethasone—multiple sclerosis	0.000577	0.00105	CcSEcCtD
Treprostinil—Abdominal pain—Betamethasone—multiple sclerosis	0.000577	0.00105	CcSEcCtD
Treprostinil—Abdominal pain—Dexamethasone—multiple sclerosis	0.000577	0.00105	CcSEcCtD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000576	0.00143	CbGpPWpGaD
Treprostinil—Asthenia—Methylprednisolone—multiple sclerosis	0.000576	0.00105	CcSEcCtD
Treprostinil—Insomnia—Prednisone—multiple sclerosis	0.000575	0.00105	CcSEcCtD
Treprostinil—PTGIR—GPCR ligand binding—CCL5—multiple sclerosis	0.000573	0.00143	CbGpPWpGaD
Treprostinil—Paraesthesia—Prednisone—multiple sclerosis	0.000571	0.00104	CcSEcCtD
Treprostinil—Pruritus—Triamcinolone—multiple sclerosis	0.000569	0.00103	CcSEcCtD
Treprostinil—Cough—Methotrexate—multiple sclerosis	0.000568	0.00103	CcSEcCtD
Treprostinil—Pruritus—Methylprednisolone—multiple sclerosis	0.000568	0.00103	CcSEcCtD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000564	0.0014	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	0.000563	0.0014	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—CCR5—multiple sclerosis	0.000561	0.0014	CbGpPWpGaD
Treprostinil—Dyspepsia—Prednisone—multiple sclerosis	0.00056	0.00102	CcSEcCtD
Treprostinil—P2RY12—Signaling Pathways—S1PR1—multiple sclerosis	0.000556	0.00138	CbGpPWpGaD
Treprostinil—Myalgia—Methotrexate—multiple sclerosis	0.000554	0.00101	CcSEcCtD
Treprostinil—Chest pain—Methotrexate—multiple sclerosis	0.000554	0.00101	CcSEcCtD
Treprostinil—Arthralgia—Methotrexate—multiple sclerosis	0.000554	0.00101	CcSEcCtD
Treprostinil—Decreased appetite—Prednisone—multiple sclerosis	0.000553	0.001	CcSEcCtD
Treprostinil—Rash—Prednisolone—multiple sclerosis	0.000552	0.001	CcSEcCtD
Treprostinil—Dermatitis—Prednisolone—multiple sclerosis	0.000551	0.001	CcSEcCtD
Treprostinil—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000549	0.000998	CcSEcCtD
Treprostinil—Fatigue—Prednisone—multiple sclerosis	0.000548	0.000996	CcSEcCtD
Treprostinil—Headache—Prednisolone—multiple sclerosis	0.000548	0.000996	CcSEcCtD
Treprostinil—Discomfort—Methotrexate—multiple sclerosis	0.000548	0.000995	CcSEcCtD
Treprostinil—PPARD—Gene Expression—RPL5—multiple sclerosis	0.000546	0.00136	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—RRM1—multiple sclerosis	0.000542	0.00135	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—GPC5—multiple sclerosis	0.000541	0.00134	CbGpPWpGaD
Treprostinil—Dizziness—Triamcinolone—multiple sclerosis	0.000532	0.000967	CcSEcCtD
Treprostinil—Dizziness—Methylprednisolone—multiple sclerosis	0.000531	0.000965	CcSEcCtD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.00053	0.00132	CbGpPWpGaD
Treprostinil—Infection—Methotrexate—multiple sclerosis	0.000528	0.000959	CcSEcCtD
Treprostinil—P2RY12—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000524	0.0013	CbGpPWpGaD
Treprostinil—Feeling abnormal—Prednisone—multiple sclerosis	0.000524	0.000952	CcSEcCtD
Treprostinil—Asthenia—Betamethasone—multiple sclerosis	0.000524	0.000952	CcSEcCtD
Treprostinil—Asthenia—Dexamethasone—multiple sclerosis	0.000524	0.000952	CcSEcCtD
Treprostinil—Thrombocytopenia—Methotrexate—multiple sclerosis	0.00052	0.000946	CcSEcCtD
Treprostinil—Gastrointestinal pain—Prednisone—multiple sclerosis	0.00052	0.000945	CcSEcCtD
Treprostinil—Nausea—Prednisolone—multiple sclerosis	0.00052	0.000945	CcSEcCtD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000519	0.00129	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—CCR5—multiple sclerosis	0.000517	0.00128	CbGpPWpGaD
Treprostinil—Pruritus—Dexamethasone—multiple sclerosis	0.000517	0.000939	CcSEcCtD
Treprostinil—Pruritus—Betamethasone—multiple sclerosis	0.000517	0.000939	CcSEcCtD
Treprostinil—Vomiting—Triamcinolone—multiple sclerosis	0.000512	0.00093	CcSEcCtD
Treprostinil—PTGIR—Signaling Pathways—S1PR1—multiple sclerosis	0.000512	0.00127	CbGpPWpGaD
Treprostinil—PPARD—Adipogenesis—IL6—multiple sclerosis	0.000511	0.00127	CbGpPWpGaD
Treprostinil—Vomiting—Methylprednisolone—multiple sclerosis	0.000511	0.000928	CcSEcCtD
Treprostinil—Rash—Triamcinolone—multiple sclerosis	0.000507	0.000922	CcSEcCtD
Treprostinil—Dermatitis—Triamcinolone—multiple sclerosis	0.000507	0.000921	CcSEcCtD
Treprostinil—Anorexia—Methotrexate—multiple sclerosis	0.000507	0.000921	CcSEcCtD
Treprostinil—Rash—Methylprednisolone—multiple sclerosis	0.000506	0.00092	CcSEcCtD
Treprostinil—P2RY12—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000506	0.00126	CbGpPWpGaD
Treprostinil—Dermatitis—Methylprednisolone—multiple sclerosis	0.000506	0.000919	CcSEcCtD
Treprostinil—Headache—Triamcinolone—multiple sclerosis	0.000504	0.000916	CcSEcCtD
Treprostinil—Headache—Methylprednisolone—multiple sclerosis	0.000503	0.000914	CcSEcCtD
Treprostinil—Abdominal pain—Prednisone—multiple sclerosis	0.000503	0.000914	CcSEcCtD
Treprostinil—Body temperature increased—Prednisone—multiple sclerosis	0.000503	0.000914	CcSEcCtD
Treprostinil—Diarrhoea—Betamethasone—multiple sclerosis	0.0005	0.000908	CcSEcCtD
Treprostinil—Diarrhoea—Dexamethasone—multiple sclerosis	0.0005	0.000908	CcSEcCtD
Treprostinil—PTGIR—Signaling Pathways—GPC5—multiple sclerosis	0.000498	0.00124	CbGpPWpGaD
Treprostinil—Hypotension—Methotrexate—multiple sclerosis	0.000497	0.000902	CcSEcCtD
Treprostinil—P2RY12—Hemostasis—IL2RA—multiple sclerosis	0.000495	0.00123	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—CCL3—multiple sclerosis	0.000494	0.00123	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—CCR2—multiple sclerosis	0.000492	0.00122	CbGpPWpGaD
Treprostinil—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000484	0.00088	CcSEcCtD
Treprostinil—Dizziness—Betamethasone—multiple sclerosis	0.000483	0.000878	CcSEcCtD
Treprostinil—Dizziness—Dexamethasone—multiple sclerosis	0.000483	0.000878	CcSEcCtD
Treprostinil—PTGIR—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000482	0.0012	CbGpPWpGaD
Treprostinil—Insomnia—Methotrexate—multiple sclerosis	0.000481	0.000874	CcSEcCtD
Treprostinil—Nausea—Triamcinolone—multiple sclerosis	0.000478	0.000869	CcSEcCtD
Treprostinil—Paraesthesia—Methotrexate—multiple sclerosis	0.000477	0.000867	CcSEcCtD
Treprostinil—Nausea—Methylprednisolone—multiple sclerosis	0.000477	0.000867	CcSEcCtD
Treprostinil—P2RY12—Signaling by GPCR—PTGER4—multiple sclerosis	0.000476	0.00118	CbGpPWpGaD
Treprostinil—Dyspnoea—Methotrexate—multiple sclerosis	0.000474	0.000861	CcSEcCtD
Treprostinil—P2RY12—Signaling Pathways—RGS1—multiple sclerosis	0.000473	0.00117	CbGpPWpGaD
Treprostinil—Dyspepsia—Methotrexate—multiple sclerosis	0.000468	0.00085	CcSEcCtD
Treprostinil—PTGIR—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000466	0.00116	CbGpPWpGaD
Treprostinil—Vomiting—Dexamethasone—multiple sclerosis	0.000464	0.000844	CcSEcCtD
Treprostinil—Vomiting—Betamethasone—multiple sclerosis	0.000464	0.000844	CcSEcCtD
Treprostinil—Decreased appetite—Methotrexate—multiple sclerosis	0.000462	0.00084	CcSEcCtD
Treprostinil—Rash—Dexamethasone—multiple sclerosis	0.00046	0.000837	CcSEcCtD
Treprostinil—Rash—Betamethasone—multiple sclerosis	0.00046	0.000837	CcSEcCtD
Treprostinil—Dermatitis—Dexamethasone—multiple sclerosis	0.00046	0.000836	CcSEcCtD
Treprostinil—Dermatitis—Betamethasone—multiple sclerosis	0.00046	0.000836	CcSEcCtD
Treprostinil—P2RY12—Signaling by GPCR—CXCR3—multiple sclerosis	0.00046	0.00114	CbGpPWpGaD
Treprostinil—Fatigue—Methotrexate—multiple sclerosis	0.000458	0.000833	CcSEcCtD
Treprostinil—Headache—Betamethasone—multiple sclerosis	0.000457	0.000831	CcSEcCtD
Treprostinil—Headache—Dexamethasone—multiple sclerosis	0.000457	0.000831	CcSEcCtD
Treprostinil—Asthenia—Prednisone—multiple sclerosis	0.000456	0.000829	CcSEcCtD
Treprostinil—PTGIR—Hemostasis—IL2RA—multiple sclerosis	0.000455	0.00113	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CCL3—multiple sclerosis	0.000455	0.00113	CbGpPWpGaD
Treprostinil—Pain—Methotrexate—multiple sclerosis	0.000454	0.000826	CcSEcCtD
Treprostinil—P2RY12—GPCR downstream signaling—CNR1—multiple sclerosis	0.000454	0.00113	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—CCR2—multiple sclerosis	0.000453	0.00113	CbGpPWpGaD
Treprostinil—Pruritus—Prednisone—multiple sclerosis	0.00045	0.000818	CcSEcCtD
Treprostinil—P2RY12—Signaling Pathways—GPR65—multiple sclerosis	0.000448	0.00111	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—CCR2—multiple sclerosis	0.000447	0.00111	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	0.000439	0.00109	CbGpPWpGaD
Treprostinil—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000439	0.00109	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—POMC—multiple sclerosis	0.000439	0.00109	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—PTGER4—multiple sclerosis	0.000438	0.00109	CbGpPWpGaD
Treprostinil—Feeling abnormal—Methotrexate—multiple sclerosis	0.000438	0.000796	CcSEcCtD
Treprostinil—Diarrhoea—Prednisone—multiple sclerosis	0.000435	0.000791	CcSEcCtD
Treprostinil—PTGIR—Signaling Pathways—RGS1—multiple sclerosis	0.000435	0.00108	CbGpPWpGaD
Treprostinil—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000435	0.00079	CcSEcCtD
Treprostinil—Nausea—Betamethasone—multiple sclerosis	0.000434	0.000788	CcSEcCtD
Treprostinil—Nausea—Dexamethasone—multiple sclerosis	0.000434	0.000788	CcSEcCtD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	0.00043	0.00107	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—PGR—multiple sclerosis	0.00043	0.00107	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—CCL2—multiple sclerosis	0.000429	0.00107	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CXCR3—multiple sclerosis	0.000423	0.00105	CbGpPWpGaD
Treprostinil—Dizziness—Prednisone—multiple sclerosis	0.000421	0.000764	CcSEcCtD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.00042	0.00104	CbGpPWpGaD
Treprostinil—Body temperature increased—Methotrexate—multiple sclerosis	0.00042	0.000763	CcSEcCtD
Treprostinil—Abdominal pain—Methotrexate—multiple sclerosis	0.00042	0.000763	CcSEcCtD
Treprostinil—PTGIR—GPCR downstream signaling—CNR1—multiple sclerosis	0.000418	0.00104	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—CNR1—multiple sclerosis	0.000413	0.00103	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—GPR65—multiple sclerosis	0.000412	0.00102	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CCR2—multiple sclerosis	0.000411	0.00102	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CXCL13—multiple sclerosis	0.00041	0.00102	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CCR1—multiple sclerosis	0.00041	0.00102	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000409	0.00102	CbGpPWpGaD
Treprostinil—Vomiting—Prednisone—multiple sclerosis	0.000404	0.000735	CcSEcCtD
Treprostinil—PTGIR—GPCR ligand binding—POMC—multiple sclerosis	0.000404	0.001	CbGpPWpGaD
Treprostinil—Rash—Prednisone—multiple sclerosis	0.000401	0.000729	CcSEcCtD
Treprostinil—Dermatitis—Prednisone—multiple sclerosis	0.000401	0.000728	CcSEcCtD
Treprostinil—Headache—Prednisone—multiple sclerosis	0.000398	0.000724	CcSEcCtD
Treprostinil—PTGIR—GPCR ligand binding—CCL2—multiple sclerosis	0.000395	0.000982	CbGpPWpGaD
Treprostinil—Asthenia—Methotrexate—multiple sclerosis	0.000381	0.000693	CcSEcCtD
Treprostinil—PTGIR—Signaling by GPCR—CNR1—multiple sclerosis	0.00038	0.000944	CbGpPWpGaD
Treprostinil—Nausea—Prednisone—multiple sclerosis	0.000378	0.000686	CcSEcCtD
Treprostinil—PTGIR—Signaling Pathways—CXCL13—multiple sclerosis	0.000377	0.000937	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CCR1—multiple sclerosis	0.000377	0.000937	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000376	0.000936	CbGpPWpGaD
Treprostinil—Pruritus—Methotrexate—multiple sclerosis	0.000376	0.000683	CcSEcCtD
Treprostinil—P2RY12—Signaling by GPCR—CXCL10—multiple sclerosis	0.000372	0.000923	CbGpPWpGaD
Treprostinil—Diarrhoea—Methotrexate—multiple sclerosis	0.000364	0.000661	CcSEcCtD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	0.000361	0.000897	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—ALB—multiple sclerosis	0.000358	0.000889	CbGpPWpGaD
Treprostinil—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000356	0.000884	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—CCL5—multiple sclerosis	0.000352	0.000875	CbGpPWpGaD
Treprostinil—Dizziness—Methotrexate—multiple sclerosis	0.000351	0.000639	CcSEcCtD
Treprostinil—PTGIR—Signaling by GPCR—CXCL10—multiple sclerosis	0.000342	0.00085	CbGpPWpGaD
Treprostinil—Vomiting—Methotrexate—multiple sclerosis	0.000338	0.000614	CcSEcCtD
Treprostinil—Rash—Methotrexate—multiple sclerosis	0.000335	0.000609	CcSEcCtD
Treprostinil—Dermatitis—Methotrexate—multiple sclerosis	0.000335	0.000608	CcSEcCtD
Treprostinil—Headache—Methotrexate—multiple sclerosis	0.000333	0.000605	CcSEcCtD
Treprostinil—PTGIR—Hemostasis—ALB—multiple sclerosis	0.000329	0.000818	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	0.000329	0.000818	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—CCL5—multiple sclerosis	0.000324	0.000805	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000323	0.000802	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000323	0.000802	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—CCL5—multiple sclerosis	0.00032	0.000795	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—CCR5—multiple sclerosis	0.000317	0.000788	CbGpPWpGaD
Treprostinil—Nausea—Methotrexate—multiple sclerosis	0.000316	0.000574	CcSEcCtD
Treprostinil—P2RY12—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000313	0.000777	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—BCHE—multiple sclerosis	0.000311	0.000773	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—VDR—multiple sclerosis	0.000301	0.000747	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CCL5—multiple sclerosis	0.000294	0.000731	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CCL3—multiple sclerosis	0.000292	0.000726	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—CCR5—multiple sclerosis	0.000292	0.000726	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—IL2—multiple sclerosis	0.00029	0.000721	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—CCR5—multiple sclerosis	0.000288	0.000716	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000288	0.000715	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—IL2RA—multiple sclerosis	0.000284	0.000706	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PTGER4—multiple sclerosis	0.000281	0.000699	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PGR—multiple sclerosis	0.000277	0.000688	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CXCR3—multiple sclerosis	0.000272	0.000675	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CD28—multiple sclerosis	0.000269	0.000668	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CCL3—multiple sclerosis	0.000269	0.000668	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—IL2—multiple sclerosis	0.000267	0.000663	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CCR5—multiple sclerosis	0.000265	0.000659	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CCR2—multiple sclerosis	0.000264	0.000656	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—IL2RA—multiple sclerosis	0.000261	0.000649	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PTGER4—multiple sclerosis	0.000259	0.000643	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PGR—multiple sclerosis	0.000255	0.000633	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CXCR3—multiple sclerosis	0.00025	0.000621	CbGpPWpGaD
Treprostinil—PPARD—Generic Transcription Pathway—MYC—multiple sclerosis	0.000248	0.000617	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—POMC—multiple sclerosis	0.000248	0.000616	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CD28—multiple sclerosis	0.000248	0.000615	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CNR1—multiple sclerosis	0.000244	0.000606	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CCR2—multiple sclerosis	0.000243	0.000604	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—POMC—multiple sclerosis	0.000228	0.000567	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—TGFB1—multiple sclerosis	0.000226	0.000562	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—POMC—multiple sclerosis	0.000225	0.00056	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CNR1—multiple sclerosis	0.000224	0.000557	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—MAPK1—multiple sclerosis	0.000222	0.000551	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—CCL2—multiple sclerosis	0.00022	0.000547	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CXCL10—multiple sclerosis	0.000219	0.000545	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—TGFB1—multiple sclerosis	0.000208	0.000517	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—POMC—multiple sclerosis	0.000207	0.000515	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—MAPK1—multiple sclerosis	0.000204	0.000507	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SRM—multiple sclerosis	0.000204	0.000507	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CCL2—multiple sclerosis	0.000203	0.000504	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CXCL10—multiple sclerosis	0.000202	0.000502	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—TYK2—multiple sclerosis	0.0002	0.000497	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CD86—multiple sclerosis	0.000192	0.000477	CbGpPWpGaD
Treprostinil—CYP2C9—Biological oxidations—POMC—multiple sclerosis	0.000189	0.00047	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CCL5—multiple sclerosis	0.000189	0.000469	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—APOE—multiple sclerosis	0.000187	0.000465	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—TYK2—multiple sclerosis	0.000184	0.000458	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—IL2—multiple sclerosis	0.000183	0.000456	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CD86—multiple sclerosis	0.000177	0.000439	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—SPP1—multiple sclerosis	0.000175	0.000435	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CCL5—multiple sclerosis	0.000174	0.000432	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CCR5—multiple sclerosis	0.00017	0.000423	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—IL2—multiple sclerosis	0.000169	0.000419	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IL2RA—multiple sclerosis	0.000168	0.000417	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—IL2—multiple sclerosis	0.000166	0.000414	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—SPP1—multiple sclerosis	0.000161	0.0004	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—POMC—multiple sclerosis	0.000161	0.000399	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CCR5—multiple sclerosis	0.000157	0.000389	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—APOE—multiple sclerosis	0.000155	0.000385	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IL2RA—multiple sclerosis	0.000154	0.000384	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—IL2—multiple sclerosis	0.000153	0.000381	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—ALB—multiple sclerosis	0.000147	0.000364	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	0.000144	0.000357	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	0.000144	0.000357	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—APOE—multiple sclerosis	0.000142	0.000354	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.00014	0.000349	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CD80—multiple sclerosis	0.00014	0.000348	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—POMC—multiple sclerosis	0.000133	0.000331	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GPC5—multiple sclerosis	0.000131	0.000327	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CCL2—multiple sclerosis	0.00013	0.000323	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CD80—multiple sclerosis	0.000129	0.00032	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—MAPK1—multiple sclerosis	0.000127	0.000316	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—POMC—multiple sclerosis	0.000122	0.000304	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CCL2—multiple sclerosis	0.00012	0.000298	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—MYC—multiple sclerosis	0.000119	0.000297	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TYK2—multiple sclerosis	0.000118	0.000294	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—MAPK1—multiple sclerosis	0.000117	0.000291	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—RRM1—multiple sclerosis	0.000109	0.000271	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TYK2—multiple sclerosis	0.000109	0.00027	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IL2—multiple sclerosis	9.83e-05	0.000244	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—IL6—multiple sclerosis	9.78e-05	0.000243	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MMP9—multiple sclerosis	9.31e-05	0.000231	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IL2—multiple sclerosis	9.05e-05	0.000225	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—IL6—multiple sclerosis	9e-05	0.000224	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MMP9—multiple sclerosis	8.57e-05	0.000213	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	8.45e-05	0.00021	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—STAT3—multiple sclerosis	8.28e-05	0.000206	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MYC—multiple sclerosis	7.69e-05	0.000191	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TGFB1—multiple sclerosis	7.67e-05	0.000191	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—STAT3—multiple sclerosis	7.62e-05	0.000189	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MAPK1—multiple sclerosis	7.52e-05	0.000187	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	7.26e-05	0.00018	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MYC—multiple sclerosis	7.08e-05	0.000176	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TGFB1—multiple sclerosis	7.06e-05	0.000175	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MAPK1—multiple sclerosis	6.92e-05	0.000172	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.62e-05	0.000164	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—BCHE—multiple sclerosis	6.25e-05	0.000155	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IL6—multiple sclerosis	5.78e-05	0.000144	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IL6—multiple sclerosis	5.32e-05	0.000132	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—APOE—multiple sclerosis	3.76e-05	9.35e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—POMC—multiple sclerosis	3.23e-05	8.03e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ALB—multiple sclerosis	2.95e-05	7.32e-05	CbGpPWpGaD
